115 related articles for article (PubMed ID: 1655148)
21. Reduced urinary excretion of dopamine and metabolites in chronic renal parenchymal disease.
Pestana M; Jardim H; Serrão P; Soares-da-Silva P; Guerra L
Kidney Blood Press Res; 1998; 21(1):59-65. PubMed ID: 9661138
[TBL] [Abstract][Full Text] [Related]
22. Endogenous dopamine synthesis and dopa-decarboxylase activity in rat renal cortex.
Wahbe F; Hagege J; Loreau N; Ardaillou R
Mol Cell Endocrinol; 1982 Jun; 27(1):45-54. PubMed ID: 7106369
[TBL] [Abstract][Full Text] [Related]
23. Kinetic study of the tubular dopamine outward transporter in the rat and dog kidney.
Soares-da-Silva P
Br J Pharmacol; 1993 Jun; 109(2):577-80. PubMed ID: 8358558
[TBL] [Abstract][Full Text] [Related]
24. Role of nitric oxide and guanosine 3',5'-cyclic monophosphate in mediating nonadrenergic, noncholinergic relaxation in guinea-pig pulmonary arteries.
Liu SF; Crawley DE; Rohde JA; Evans TW; Barnes PJ
Br J Pharmacol; 1992 Nov; 107(3):861-6. PubMed ID: 1335345
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory effect of nitrovasodilators and cyclic GMP on ET-1-activated Ca(2+)-permeable nonselective cation channel in rat aortic smooth muscle cells.
Minowa T; Miwa S; Kobayashi S; Enoki T; Zhang XF; Komuro T; Iwamuro Y; Masaki T
Br J Pharmacol; 1997 Apr; 120(8):1536-44. PubMed ID: 9113376
[TBL] [Abstract][Full Text] [Related]
26. Role of selective cyclic GMP phosphodiesterase inhibition in the myorelaxant actions of M&B 22,948, MY-5445, vinpocetine and 1-methyl-3-isobutyl-8-(methylamino)xanthine.
Souness JE; Brazdil R; Diocee BK; Jordan R
Br J Pharmacol; 1989 Nov; 98(3):725-34. PubMed ID: 2480168
[TBL] [Abstract][Full Text] [Related]
27. Tonic inhibitory action by nitric oxide on spontaneous mechanical activity in rat proximal colon: involvement of cyclic GMP and apamin-sensitive K+ channels.
Mulè F; D'Angelo S; Serio R
Br J Pharmacol; 1999 May; 127(2):514-20. PubMed ID: 10385253
[TBL] [Abstract][Full Text] [Related]
28. Induction of dopamine biosynthesis by l-DOPA in PC12 cells: implications of L-DOPA influx and cyclic AMP.
Jin CM; Yang YJ; Huang HS; Lim SC; Kai M; Lee MK
Eur J Pharmacol; 2008 Sep; 591(1-3):88-95. PubMed ID: 18602388
[TBL] [Abstract][Full Text] [Related]
29. Steroidogenic effect of atrial natriuretic factor in isolated mouse Leydig cells is mediated by cyclic GMP.
Mukhopadhyay AK; Schumacher M; Leidenberger FA
Biochem J; 1986 Oct; 239(2):463-7. PubMed ID: 3028372
[TBL] [Abstract][Full Text] [Related]
30. Involvement of cyclic GMP in non-adrenergic, non-cholinergic inhibitory neurotransmission in dog proximal colon.
Ward SM; Dalziel HH; Bradley ME; Buxton IL; Keef K; Westfall DP; Sanders KM
Br J Pharmacol; 1992 Dec; 107(4):1075-82. PubMed ID: 1334749
[TBL] [Abstract][Full Text] [Related]
31. Characterization of in vitro dopamine synthesis in the median eminence of rats with haloperidol-induced hyperprolactinemia and bromocriptine-induced hypoprolactinemia.
Arita J; Kimura F
Endocrinology; 1986 Oct; 119(4):1666-72. PubMed ID: 3019639
[TBL] [Abstract][Full Text] [Related]
32. Regulation of dopamine synthesis in the rat kidney.
Soares-da-Silva P; Fernandes MH
J Auton Pharmacol; 1990; 10 Suppl 1():s25-30. PubMed ID: 2098374
[TBL] [Abstract][Full Text] [Related]
33. Direct inhibitory effect of long term estradiol treatment on dopamine synthesis in tuberoinfundibular dopaminergic neurons: in vitro studies using hypothalamic slices.
Arita J; Kimura F
Endocrinology; 1987 Aug; 121(2):692-8. PubMed ID: 3036480
[TBL] [Abstract][Full Text] [Related]
34. The effects of sodium nitroprusside and 8-bromo-cyclic GMP on electrical and mechanical activities of the rat tail artery.
Cheung DW; MacKay MJ
Br J Pharmacol; 1985 Sep; 86(1):117-24. PubMed ID: 2996672
[TBL] [Abstract][Full Text] [Related]
35. Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine.
Jackson D; Abercrombie ED; Zigmond MJ
J Pharmacol Exp Ther; 1993 Nov; 267(2):912-8. PubMed ID: 8246167
[TBL] [Abstract][Full Text] [Related]
36. Demethylation of 3-O-methyldopa in the kidney: a possible source for dopamine in urine.
Ibarra FR; Aguirre J; Nowicki S; Barontini M; Arrizurieta EE; Armando I
Am J Physiol; 1996 May; 270(5 Pt 2):F862-8. PubMed ID: 8928849
[TBL] [Abstract][Full Text] [Related]
37. Is the muscarinic receptor that mediates potentiation of dopamine release negatively coupled to the cyclic GMP system?
Marchi M; Paudice P; Gemignani A; Raiteri M
J Neurosci Res; 1987; 17(2):142-5. PubMed ID: 2438426
[TBL] [Abstract][Full Text] [Related]
38. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
Marcoz P; Prigent AF; Lagarde M; Nemoz G
Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
[TBL] [Abstract][Full Text] [Related]
39. Enkephalin inhibits dopamine synthesis in vitro in the median eminence portion of rat hypothalamic slices.
Arita JA; Kimura K
Endocrinology; 1988 Aug; 123(2):694-9. PubMed ID: 3135174
[TBL] [Abstract][Full Text] [Related]
40. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
Biggs CS; Starr MS
Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
